Kolon Life cancelled for ‘Invossa’ technology export agreement with Mitsubishi Tanabe

Published: 2018-05-02 17:40:06

Updated: 2018-05-02 17:40:06

When it comes to the Invossa technology export, Kolon Life Science officially announced on the 27^th, “Mitsubishi Tanabe Pharma filed mediation at the International Chamber of Commerce. The mediation will be proceeded under the International Chamber of Commerce rules, and will made an official notice without hesitation if the mediation is confirmed in the future.”

This official notice is a foll...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.